[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Stmkrs Avatar @Stmkrs Biotech Pharma Investor

Biotech Pharma Investor posts on X about $jspr, $cldx, $achv, $14b the most. They currently have XX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence finance

Social topic influence $jspr, $cldx, $achv, $14b, $46m, $dmac, $500m, accounting, $qnrx, $aztr

Top assets mentioned Celldex Therapeutics, Inc (CLDX)

Top Social Posts #

Top posts by engagements in the last XX hours

"$jspr $CLDX Better pk (q8w dosing) Better safety Better efficacy JSPR MC $46M vs CLDX MC $1.4B Of course CLDX is much more advanced in clinical development + has cash (vs JSPR that needs to raise NOW). Still the valuation gap is crazy"
@Stmkrs Avatar @Stmkrs on X 2025-07-08 03:58:57 UTC XX followers, XXX engagements

"$dmac very interesting results. DMAC potential to enter X multibillion $ markets. I dont get current valuation. Stroke interim readout within cash runway but company will probably raise before that"
@Stmkrs Avatar @Stmkrs on X 2025-07-17 12:59:57 UTC XX followers, XXX engagements

"@PirateWaffle What bounce If news are valid it will be a huge hit to SRPT's plan Their worst case scenario accounting for $500M annual revenue by Elevidys which seems will be zero. Lot more downside if withdrawal of Elevidys is announced officially"
@Stmkrs Avatar @Stmkrs on X 2025-07-18 18:00:53 UTC XX followers, XX engagements

"@PirateWaffle Unless you are planning to buy then"
@Stmkrs Avatar @Stmkrs on X 2025-07-18 18:32:15 UTC XX followers, XX engagements

"@BioValues $VYNE $KALA $JSPR $EVAX $CAPR $SGMO $NUVB $QURE $AZTR $QNRX"
@Stmkrs Avatar @Stmkrs on X 2025-07-13 04:44:52 UTC XX followers, 1929 engagements

"$JSPR $CLDX "Mild" based on whom Based on assessing clinicians I don't think patients would consider such skin changes mild. Zero skin discoloration in JSPR studies so far"
@Stmkrs Avatar @Stmkrs on X 2025-07-08 04:28:27 UTC XX followers, XXX engagements